Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Immucor -- Ignore unavailable to you. Want to Upgrade?

To: Thomas Kirwin who wrote (335)	7/16/1999 2:15:00 AM
From: sim1	Read Replies (1) \| Respond to of 422

Tom, Thanks for sharing this very positive article here. Growth prospects appear to be very bright over the next several years. BTW, do you or anyone else have any idea what (if any) the Red Cross take on BLUD products might be? Seems to me that this kind of support could provide a world wide standard, having consistent and assured safety that could support a network of individual local blood banks participating as members of a "global" blood bank. I realize that this kind of arrangement already exists to a limited extent (within national boundaries) today. A truly global blood bank would require reduced inventory (and therefore reduced costs), while not compromising the safety of any of the blood recipients throughout the network. I smell some real potential here and I think a combination of automation, increased (technition) costs, reduced product (future blood donations), and an increasing competition among public and private blood banks could be catalyst. Just some clueless speculation on my part. Any comments... Yes? No? Perhaps?